Guardant Health
GH
#1126
Rank
โ‚น2.098 T
Marketcap
โ‚น15,639
Share price
2.01%
Change (1 day)
206.84%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -โ‚น303.54

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น324.57. In 2025 the company made an earnings per share (EPS) of -โ‚น316.91 an increase over its 2024 EPS that were of -โ‚น340.85.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น303.54-4.22%
2025-โ‚น316.91-7.02%
2024-โ‚น340.85-16.82%
2023-โ‚น409.78-33.13%
2022-โ‚น612.7660%
2021-โ‚น382.9755.04%
2020-โ‚น247.02207.14%
2019-โ‚น80.42-19.81%
2018-โ‚น100.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น268.71-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น237.44-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA